{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Furley%20Bioextracts%20SDN%20BHD","name":"Furley Bioextracts SDN BHD","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-03T16:52:48.498Z"},"count":1,"matches":[{"id":"99342823a6a5ac74","posted_date":"2021-09-21","letter_issue_date":"2021-09-13","company_name":"Furley Bioextracts SDN BHD","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/99342823a6a5ac74"}]}